Orofacial granulomatosis (OFG) is a term encompassing a group of immunologically mediated, recurrent or persistent, inflammatory granulomatous entities that manifest as soft-tissue enlargement of the lips and orofacial area.1 The precise cause of OFG is not fully understood and literature suggests that allergies, infections, or genetic predisposition may play a role. Studies have hypothesized that OFG is associated with, or may be a subtype of, Crohn disease.2 Management of OFG is challenging owing to its chronicity, aesthetic impact, and poor response to treatment.1,3 Herein, we report a novel surgical treatment for a rare clinical manifestation of OFG.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Honigman AD, Kim M, Chow C, Robertson SJ. Orofacial Granulomatosis Presenting With Acquired Lymphangiectasia. JAMA Dermatol. 2019;155(11):1320–1321. doi:10.1001/jamadermatol.2019.2689
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: